Lattice Medical is a developer of a medtech company designed to help manufacture and design soft tissue reconstruction devices for breast reconstruction
Breast reconstruction commonly requires permanent implants or complex tissue-transfer surgery.
R&D Focus
Resorbable implants, tissue regeneration and 3D-printed soft-tissue reconstruction devices.
Innovative Solution
MATTISSE is a resorbable scaffold intended to support the patient’s own tissue regeneration and then gradually disappear.
Investment Funding
Last Funding Stage
Series B
Total Funding Amount
$13.5M
Last Funding Amount
$6.54 M
Last Funding Date
1/17/2024
Startup Stage
Growth Stage
Lead Investors
MedTech Innovator, European Innovation Council Fund, DGA France, Bpifrance, EIT Health
People
Founders
Julien Payen
Pierre Guerreschi
Pierre-Marie Danze
Philippe Marchetti
CEO
Julien Payen
About
Lattice Medical is a developer of a medtech company designed to help manufacture and design soft tissue reconstruction devices for breast reconstruction
Products
Product
MATTISSE breast-reconstruction implant and RODIN tissue-regeneration matrix.
Star Product
MATTISSE, because it is the lead resorbable breast-reconstruction device and the focus of clinical development.
Demo Product or Complete Product?
Clinical development and regulatory stage; MATTISSE is not yet a broadly commercial implant.
Future Plan
Market Expansion
Funding supports regulatory development and future entry into European and international reconstructive-surgery markets.
Investment Funding
Raised €43 million in 2025; also secured €6 million through France 2030 support in 2024.
Awards and Recognitions
Awards
European Innovation Council Accelerator selection.
M&A and Collabs
Collab
ONCOLille and INSERM: clinical and translational research collaboration.
Collab
European clinical centers: MATTISSE clinical investigation and validation.
Something missing or incorrect on this page? Help us enrich this information
